FELI-CELL Trademark

Trademark Overview

On Friday, February 21, 2020, a trademark application was filed for FELI-CELL with the United States Patent and Trademark Office. The USPTO has given the FELI-CELL trademark a serial number of 79282223. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Friday, March 10, 2023. This trademark is owned by GLOBAL STEM CELL TECHNOLOGY, afgekort G.S.T., naamloze vennootschap. The FELI-CELL trademark is filed in the Pharmaceutical Products category with the following description:

Veterinary preparations, namely, stem cells for veterinary purposes; surgical implants comprised of living tissues grown from stem cells, for animals; dietary supplements for animals; all of the foregoing goods for the treatment of chronic kidney disease, stomatitis, pain and inflammation
feli-cell

General Information

Serial Number79282223
Word MarkFELI-CELL
Filing DateFriday, February 21, 2020
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateFriday, March 10, 2023
Registration Number6331064
Registration DateTuesday, April 27, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 9, 2021

Trademark Statements

Goods and ServicesVeterinary preparations, namely, stem cells for veterinary purposes; surgical implants comprised of living tissues grown from stem cells, for animals; dietary supplements for animals; all of the foregoing goods for the treatment of chronic kidney disease, stomatitis, pain and inflammation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateFriday, March 10, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBoehringer Ingelheim Veterinary Medicine Belgium, naamloze vennootschap
Party Type30 - Original Registrant
Legal Entity Type32 - NOT AVAILABLE
AddressBE
Party NameGLOBAL STEM CELL TECHNOLOGY, afgekort G.S.T., naamloze vennootschap
Party Type20 - Owner at Publication
Legal Entity Type32 - NOT AVAILABLE
AddressBE
Party NameGLOBAL STEM CELL TECHNOLOGY, afgekort G.S.T., naamloze vennootschap
Party Type10 - Original Applicant
Legal Entity Type32 - NOT AVAILABLE
AddressBE

Trademark Events

Event DateEvent Description
Tuesday, June 6, 2023CANCELLATION TERMINATED NO. 999999
Tuesday, June 6, 2023CANCELLATION GRANTED NO. 999999
Tuesday, March 28, 2023NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Tuesday, March 28, 2023DEATH OF INTERNATIONAL REGISTRATION
Monday, February 27, 2023CANCELLATION INSTITUTED NO. 999999
Friday, December 31, 2021CHANGE OF NAME/ADDRESS REC'D FROM IB
Monday, October 4, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, August 11, 2021GENERIC MADRID TRANSACTION SENT TO IB
Wednesday, August 11, 2021GENERIC MADRID TRANSACTION CREATED
Tuesday, July 27, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, April 27, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, February 9, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 9, 2021PUBLISHED FOR OPPOSITION
Saturday, February 6, 2021NOTIFICATION PROCESSED BY IB
Wednesday, January 20, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 20, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 20, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 7, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 7, 2021EXAMINER'S AMENDMENT ENTERED
Thursday, January 7, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, January 7, 2021EXAMINERS AMENDMENT E-MAILED
Thursday, January 7, 2021EXAMINERS AMENDMENT -WRITTEN
Monday, December 7, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 7, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 7, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, August 4, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, August 4, 2020FINAL REFUSAL E-MAILED
Tuesday, August 4, 2020FINAL REFUSAL WRITTEN
Monday, July 20, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 20, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 20, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 3, 2020REFUSAL PROCESSED BY IB
Tuesday, June 16, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, June 16, 2020REFUSAL PROCESSED BY MPU
Friday, May 15, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, May 14, 2020NON-FINAL ACTION WRITTEN
Monday, May 11, 2020ASSIGNED TO EXAMINER
Tuesday, April 7, 2020APPLICATION FILING RECEIPT MAILED
Friday, April 3, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 2, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

cell feli cells veterinary stem animals treatment goods foregoing chronic disease inflammation